Today: 17 May 2026
BMW AG’s China Fight Just Got Harder as Neue Klasse EVs Take Beijing
26 April 2026
2 mins read

BMW AG’s China Fight Just Got Harder as Neue Klasse EVs Take Beijing

BEIJING, April 27, 2026, 02:45 CST

  • BMW plans to spotlight several China-tailored Neue Klasse EVs at Auto China 2026, rolling out both the iX3 Long Wheelbase and the i3 Long Wheelbase.
  • BMW and MINI saw first-quarter sales in China slip 10%, though Europe managed to post gains. The launch follows that dip.
  • German automakers are feeling the heat as Chinese competitors like Geely and Nio intensify the battle for premium car buyers.

BMW AG’s latest move in China: the German automaker is spotlighting two electric models tailored for the local market—the iX3 Long Wheelbase and i3 Long Wheelbase—plus the new 7 Series, making their global debuts at the Beijing auto show. It’s a crucial moment for German luxury players trying to reclaim momentum in what’s arguably the world’s fiercest auto arena. All three launches are part of BMW’s Neue Klasse tech initiative.

Awkward timing for BMW: the company posted a 3.5% slide in global deliveries for the first quarter, totaling 565,748 vehicles. BMW and MINI sales fell sharply in China, down 10%, and slipped 4.3% in the U.S.—Europe was the lone bright spot, up 3%.

Premium foreign brands are finding China a tougher environment. Hildegard Mueller, who heads Germany’s VDA auto lobby, told reporters in Beijing that “the competition in the Chinese market is the most intense competition in the world.” She added that German automakers can’t rely on past market share as the standard for success anymore. Reuters

BMW is putting the spotlight on Neue Klasse at Auto China, showcasing its fresh electric-vehicle and software platform. The entire stand is dedicated to this architecture, featuring the BMW Panoramic iDrive—designed specifically for the Chinese market—and new driver-assistance tech built for local traffic.

Oliver Zipse, the chief executive, called the launches “a major leap” for technology, design, and driving experience. He said BMW plans to roll out the new technology and fresh design language throughout its portfolio. BMW Group PressClub

BMW says its iX3 Long Wheelbase and i3 Long Wheelbase are the debut Neue Klasse vehicles tailor-made in China for the local market. Both models, according to BMW, post strong numbers on China’s CLTC test: the iX3 manages over 900 kilometres of range, and the i3 tops 1,000 kilometres. An 800-volt system lets drivers add as much as 400 kilometres in just 10 minutes at a high-speed charger.

BMW is pushing its Neue Klasse tech upmarket with the 7 Series, aiming for the same message at the flagship tier. The company calls the sedan the first in its luxury class to integrate Neue Klasse features into an established model line. Fully electric versions will top 720 kilometres—447 miles—on the WLTP test cycle, according to BMW. Production and a global rollout are scheduled to begin in July 2026.

You can see the pressure among peers right on the show floor. According to Reuters, Chinese automakers like Geely and Nio are pushing into the premium end, offering high-tech models that undercut German staples BMW and Mercedes-Benz on price. Bo Yu, who manages Greater China at JATO Dynamics, described the change as moving away from a price war and straight into what he called a “value-for-money war.” Reuters

BMW’s momentum looks stronger in Europe. The automaker reported a roughly 40% jump in European BEV orders for the first quarter, with more than 50,000 iX3 orders logged since the regional launch. “Demand was exceeding our high expectations,” said Jochen Goller, who oversees customer, brands and sales for BMW. BMW Group PressClub

China, though, stands out as the major risk. Mueller pointed out that local manufacturers are already taking on a larger role “now and in future.” He flagged sluggish consumer demand, especially weighing on car sales in the upper luxury segment. If domestic brands keep winning buyers with quicker software updates and cheaper prices, BMW’s edge with longer range and premium cabins might not cut it. Reuters

So BMW finds itself threading a thin line: it needs to steady its footing in China, but can’t afford to dive into a profit-shredding price war. Rolling out new models in Beijing sets out a firmer product pitch, yet the real test is more straightforward — can the iX3, i3, and 7 Series take their tech from the spotlight to actual sales, now that the BMW name alone doesn’t guarantee buyers in this market?

Stock Market Today

  • Indian Stock Market Outlook: Sensex and Nifty 50 Face Volatility Amid US-Iran Tensions
    May 17, 2026, 2:04 AM EDT. Indian stock markets ended the week lower, breaking a three-week consolidation as geopolitical tensions between the US and Iran escalate. Sensex slipped 161 points to 75,237.99, while Nifty 50 dropped 46 points to 23,643.50. Factors include a weakening rupee and rising crude oil prices amid inflation concerns. Experts expect continued market volatility next week, with investor sentiment closely tied to developments around the Strait of Hormuz, crucial for global energy supply. Key technical levels to watch: Sensex resistance between 75,600-76,000, support at 74,200-74,500; Nifty resistance at 24,000-24,250, support near 23,000-23,250. Caution and strict stop-loss strategies advised as geopolitical risks and energy market disruptions persist.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
D-Wave Quantum Stock Slides Before Q1 Earnings as Investors Look for Proof Behind the Rally
Previous Story

D-Wave Quantum Stock Slides Before Q1 Earnings as Investors Look for Proof Behind the Rally

Vistra Stock Pops 4.8% as VST’s AI Power Trade Faces Its Next Test
Next Story

Vistra Stock Pops 4.8% as VST’s AI Power Trade Faces Its Next Test

Go toTop